Huw Thomas Dr Christopher Calabrese Michael Batey Suzanne Kyle Professor Herbie Newell et al. | Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial | 2007 |
|
Huw Thomas Dr Christopher Calabrese Professor Herbie Newell Lan Wang Professor Nicola Curtin et al. | Identification of a PARP inhibitor for clinical trial: Preclinical studies | 2006 |
|
Dr Christopher Calabrese Professor Heinz Grunze
| Influence of sub-syndromal symptoms after remission from manic or mixed episodes | 2006 |
|
Dr Christopher Calabrese Professor Steven Clifford Dr Richard Gilbertson
| The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation | 2005 |
|
Dr Christopher Calabrese Professor Steven Clifford Dr Richard Gilbertson
| The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation | 2005 |
|
Dr Christopher Calabrese Michael Batey Professor Alan Calvert Professor barbara Durkacz Suzanne Kyle et al. | Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361 | 2004 |
|
Dr Christopher Calabrese Professor Nicola Curtin Suzanne Kyle Huw Thomas Lan Wang et al. | Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1- hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase | 2004 |
|
Dr Christopher Calabrese Michael Batey Huw Thomas Professor barbara Durkacz Lan Wang et al. | Identification of potent nontoxic poly(ADP-ribose) polymerase-1 inhibitors: Chemopotentiation and pharmacological studies | 2003 |
|
Dr Christopher Calabrese Professor Nicola Curtin Suzanne Kyle Huw Thomas Lan Wang et al. | Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure | 2002 |
|
Professor Nicola Curtin Dr Stephen Barton Michael Batey Dr Christopher Calabrese Professor Alan Calvert et al. | Anti-cancer chemosensitization in vitro and in vivo by a novel potent poly(ADP-ribose) polymerase (PARP1) inhibitor, TBI-361. | 2001 |
|
Dr Christopher Calabrese
| Separation methods for anthraquinone related anti-cancer drugs | 2001 |
|
Dr Christopher Calabrese
| Separation methods for anthraquinone related anti-cancer drugs | 2001 |
|
Dr Christopher Calabrese Professor Nicola Curtin Michael Batey Huw Thomas Suzanne Kyle et al. | Design and evaluation of novel potent inhibitors of poly (ADP-ribose) polymerase | 2000 |
|
Dr Christopher Calabrese Huw Thomas Alex White
| Preclinical pharmacology of novel potent inhibitors of PARP | 1999 |
|
Dr Christopher Calabrese Huw Thomas Michael Batey Professor Nicola Curtin Professor Roger Griffin et al. | Preclinical pharmacology of novel substituted benzimidazoles - potent inhibitors of poly (ADP-ribose) polymerase | 1999 |
|